FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely oncology, and may be used to produce a medicinal product for treating a proliferative disease in an individual. That is ensured by using a composition containing taxane and carrier protein nanopaticles in a combination with an effective amount of at least one other agent specified in decitabine and azacitidine. Azacitidine is applicable for oral administration. What is also presented is a kit for treating a proliferative disease.
EFFECT: group of inventions provides treating diseases by synergetic action of the composition containing taxane and carrier protein nanopaticles in a combination with decitabine.
41 cl, 3 dwg, 7 tbl, 11 ex
